Reddy S - Search Results

1

Liquid biopsy proteomics of uveal melanoma reveals biomarkers associated with metastatic risk.

Velez G, Nguyen HV, Chemudupati T, Ludwig CA, Toral M, Reddy S, Mruthyunjaya P, Mahajan VB. Velez G, et al. Among authors: reddy s. Mol Cancer. 2021 Feb 24;20(1):39. doi: 10.1186/s12943-021-01336-4. Mol Cancer. 2021. PMID: 33627107 Free PMC article. No abstract available.

2

"Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma".

Narala R, Reddy SA, Mruthyunjaya P. Narala R, et al. Am J Ophthalmol Case Rep. 2020 Aug 25;20:100891. doi: 10.1016/j.ajoc.2020.100891. eCollection 2020 Dec. Am J Ophthalmol Case Rep. 2020. PMID: 32913923 Free PMC article.

3

A Prospective Clinical Trial Combining Radiation Therapy With Systemic Immunotherapy in Metastatic Melanoma.

Hiniker SM, Reddy SA, Maecker HT, Subrahmanyam PB, Rosenberg-Hasson Y, Swetter SM, Saha S, Shura L, Knox SJ. Hiniker SM, et al. Among authors: reddy sa. Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):578-88. doi: 10.1016/j.ijrobp.2016.07.005. Epub 2016 Jul 15. Int J Radiat Oncol Biol Phys. 2016. PMID: 27681753 Free PMC article. Clinical Trial.

4

Phase I Trial: SABR and Ipilimumab-Letter.

Hiniker SM, Reddy SA, Swetter SM, Knox SJ. Hiniker SM, et al. Clin Cancer Res. 2017 Jan 1;23(1):320. doi: 10.1158/1078-0432.CCR-16-2495. Clin Cancer Res. 2017. PMID: 28049160 No abstract available.

5

Prognostic value of volumetric PET parameters at early response evaluation in melanoma patients treated with immunotherapy.

Nakamoto R, Zaba LC, Rosenberg J, Reddy SA, Nobashi TW, Davidzon G, Aparici CM, Nguyen J, Moradi F, Iagaru A, Franc BL. Nakamoto R, et al. Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2787-2795. doi: 10.1007/s00259-020-04792-0. Epub 2020 Apr 15. Eur J Nucl Med Mol Imaging. 2020. PMID: 32296882

6

Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab.

Sodji QH, Gutkin PM, Swetter SM, Reddy SA, Hiniker SM, Knox SJ. Sodji QH, et al. Melanoma Manag. 2020 Feb 12;7(1):MMT36. doi: 10.2217/mmt-2019-0020. Melanoma Manag. 2020. PMID: 32399174 Free PMC article.

7

Intracranial Tumor Control After Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.

Zhang M, Rodrigues AJ, Bhambhvani HP, Fatemi P, Pollom EL, Gibbs IC, Thomas RP, Soltys SG, Hancock SL, Chang SD, Reddy SA, Gephart MH, Li G. Zhang M, et al. World Neurosurg. 2020 Dec;144:e316-e325. doi: 10.1016/j.wneu.2020.08.124. Epub 2020 Aug 24. World Neurosurg. 2020. PMID: 32853767

8

Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020.

Qian MF, Betancourt NJ, Pineda A, Maloney NJ, Nguyen KA, Reddy SA, Hall ET, Swetter SM, Zaba LC. Qian MF, et al. Oncologist. 2023 Mar 17;28(3):268-275. doi: 10.1093/oncolo/oyac219. Oncologist. 2023. PMID: 36302223 Free PMC article.

9

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

Hiniker SM, Chen DS, Reddy S, Chang DT, Jones JC, Mollick JA, Swetter SM, Knox SJ. Hiniker SM, et al. Among authors: reddy s. Transl Oncol. 2012 Dec;5(6):404-7. doi: 10.1593/tlo.12280. Epub 2012 Dec 1. Transl Oncol. 2012. PMID: 23323154 Free PMC article.

10

Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up.

Gutkin PM, Hiniker SM, Swetter SM, Reddy SA, Knox SJ. Gutkin PM, et al. Cureus. 2018 Dec 12;10(12):e3723. doi: 10.7759/cureus.3723. Cureus. 2018. PMID: 30788205 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,388 results

Search Page

Filters